BioNTech SE (BNTX) Change in Accured Expenses (2018 - 2019)
BioNTech SE (BNTX) reported Change in Accured Expenses of $66.3 million for Q4 2019, up 600.81% on a YoY basis from $9.5 million in Q4 2018, and up 600.81% sequentially from $9.5 million in Q4 2018.
BioNTech SE (BNTX) Change in Accured Expenses (2018 - 2019) Analysis & Trends
BioNTech SE (BNTX) has 2 years of Change in Accured Expenses data on file, last reported at $66.3 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 66.33 Mn |
| Dec 31, 2019 | 66.33 Mn |
| Dec 31, 2018 | 9.46 Mn |
| Dec 31, 2018 | 9.46 Mn |